News for Surgery Partners, Inc. (SGRY)

Surgery Partners, Inc. (SGRY) is set to release its Q2 2025 earnings on August 5, 2025, before the market opens. A conference call to discuss the result

Summary Surgery Partners Inc (SGRY), a prominent owner and operator of short-stay surgical facilities, has announced that it will release its second quarter 202

BRENTWOOD, Tenn., July 18, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facilit

BRENTWOOD, Tenn., July 18, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ('Surgery Partners' or the 'Company'), a leading short-stay surgical facility owner and operator, announced the Company will release its second quarter 2025 results before the market opens on Tuesday, August 5, 2025, to be followed by a conference call at 8:30 a.m. (Eastern Time).

On June 30, 2025, JANUS HENDERSON GROUP PLC (Trades, Portfolio) executed a significant transaction involving Surgery Partners Inc (SGRY). The firm added 1,311,8

Shares of Surgery Partners Inc (SGRY) fell 3.60% in mid-day trading on Jun 20. The stock reached an intraday low of $18.87, before recovering slightly to $19.

Surgery Partners, Inc. declines Bain Capital's $25.75/share offer, citing growth potential. Click for my updated look at SGRY stock following its selloff.

Shares of Surgery Partners Inc (SGRY) fell 13.55% in mid-day trading on Jun 17. The stock reached an intraday low of $19.79, before recovering slightly to $20

Shares of Surgery Partners Inc (SGRY) surged 4.94% in mid-day trading on May 30. The stock reached an intraday high of $23.96, before settling at $23.93, up

In recent developments concerning Surgery Partners (SGRY), Barclays analyst Andrew Mok has updated his stance on the company's stock. The analyst has maintained

On May 27, Barclays analyst Andrew Mok CFA maintained an Equal Weight rating on Surgery Partners, Inc. (NASDAQ:SGRY) and reduced the price target to $24 from $25. The rating update came after Surgery Partners, Inc. (NASDAQ:SGRY) reported mixed fiscal Q1 2025 results on May 12. The analyst told investors in a research update that while […]

Barclays analyst Andrew Mok has adjusted the price target for Surgery Partners (SGRY) from $25 to $24, while maintaining an Equal Weight rating on the stock. Th

On May 15, 2025, Hein Park Capital Management LP (Trades, Portfolio) executed a notable transaction involving Diebold Nixdorf Inc. The firm reduced its holdings

Revenue growth and strategic acquisitions signal strength amidst competitive healthcare landscape.Operational challenges reflected in net loss, highlighting ar

Net Revenue: $776 million, an 8.2% increase from the first quarter of 2024.Adjusted EBITDA: $103.9 million, representing a margin of 13.4%.Same-Facility Revenu

May 12, 2025 / 12:30PM GMTOperator Greetings, and welcome to Surgery Partners' first quarter 2025 earnings call. (Operator Instructions) As a reminder, this con

Investment Highlights: Surgery Partners (SGRY) reports a significant increase in first-quarter 2025 revenue. Analysts forecast a substantial potential up

Discover key takeaways from Surgery Partners' Q1 2025 earnings call.

Surgery Partners, Inc. (NASDAQ:SGRY) Q1 2025 Earnings Conference Call May 12, 2025 8:30 AM ETCompany ParticipantsEric Evans - Chief Executive OfficerDavid...